Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Corin helps control salt and sweat release in sweat glands.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

PRP is an effective and safe treatment for hair loss in women.

GALT5 and GALT2 are important for plant growth and development because they help with protein glycosylation.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Gastric bypass surgery improved a woman's hormonal disorder without the need for medication.

FGF10 and non-coding RNAs are important for cashmere goat hair follicle development.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

How bad a woman's hair loss is doesn't always match how it affects her happiness and daily life.

AXR3 and SHY2 genes control the growth and timing of root hair development in plants.

Nonclassic congenital adrenal hyperplasia is a common genetic disorder that can cause a range of symptoms and requires personalized treatment.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

A patient with complete hair loss regrew all her hair using tofacitinib.